Regulation - Asia-Pacific, Takeda Pharmaceuticals

Filter

Popular Filters

Takeda to commercialize Teva’s glatiramer acetate for MS in Japan

Takeda to commercialize Teva’s glatiramer acetate for MS in Japan

05-12-2013

Revealing an earlier agreement yesterday, Israel’s Teva Pharmaceutical Industries and Japan’s largest…

Asia-PacificCopaxoneGlatiramer AcetateLicensingNeurologicalPharmaceuticalRegulationTakeda PharmaceuticalsTeva Pharmaceutical Industries

Indication changes for Glufast approved in Japan

13-09-2013

Japanese drugmakers Kissei Pharmaceutical (TYO: 4547) and Takeda Pharmaceutical (TYO: 4502) have received…

Asia-PacificDiabetesGlufastKissei PharmaceuticalPharmaceuticalRegulationTakeda Pharmaceuticals

Takeda gains Chinese approval for diabetes drug

31-07-2013

Japan's largest drugmaker, Takeda Pharmaceutical (TYO: 4502), says that the China Food and Drug Administration…

Asia-PacificDiabetesNesinaPharmaceuticalRegulationSanofiTakeda Pharmaceuticals

Japan briefs: Takeda files for Azilva comb; Sandoz seeks filgrastim biosimilar approval

29-04-2013

Japan's largest drugmaker Takeda Pharmaceutical (TYO: 4502) says that it submitted a New Drug Application…

Amlodipine BesylateAsia-PacificAzilvaBiotechnologyCardio-vascularEP2006FilgrastimGenericsImmunologicalsNovartisPharmaceuticalRegulationSandozTakeda PharmaceuticalsZarzio

Takeda files for brentuximab vedotin approval in Japan; sanctioned by JPMA

22-03-2013

Japan's largest drugmaker, Takeda Pharmaceutical (TYO: 4502) and its oncology subsidiary Millennium have…

AdcetrisAlinamin-F5Asia-PacificbrentuximabMillennium LaboratoriesOncologyPharmaceuticalRegulationSeattle GeneticsTakeda Pharmaceuticals

Takeda called on to take corrective action over Alinamin-F5 marketing and manufacturing

15-02-2013

Japan's largest drugmaker Takeda Pharmaceutical (TYO: 4502) revealed it has received an Order for Corrective…

Alinamin-F5Asia-PacificPharmaceuticalProductionRegulationTakeda Pharmaceuticals

Pharmaceutical majors unite in Japan to combat H. pylori

18-09-2012

On August 31, nine pharmaceutical companies operating in Japan (Kyowa Hakko Kirin, Takeda Pharmaceutical,…

Antibiotics and Infectious diseasesAsia-PacificAstraZenecaGastro-intestinalsPharmaceuticalRegulationTakeda Pharmaceuticals

Back to top